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Dear Editor,
The aim of the study carried out by Alavian et al. (2011) 
is to determine anti-HBs antibody titer in dental health 
providers and to investigate the possible correlation be-
tween the level of immunity and a number of relevant 
factors (1). Hepatitis B virus (HBV) is still the major cause 
of infection in most parts of the world and therefore is 
a serious global public health problem. About 2 billion 
people worldwide have been infected with the virus, and 
about 350 million live with chronic infection (2). HBV is 
transmitted primarily through blood and sexual routes, 
similar to HIV and hepatitis C virus (HCV) (3-5). Further-
more, HBV is an occupational hazard for health workers 
(2), who might be discouraged to work for infected pa-
tients. According to the recommendations of the Word 
Health Organization (WHO), all infants should receive 
their first dose of the hepatitis B vaccine immediately af-
ter birth, preferably within 24 hours. This is crucial not 
only in areas in which hepatitis B is highly prevalent, 
but also important in intermediate- and low-prevalent 
areas. Delivery of hepatitis B vaccine within 24 hours of 
birth should be a performance measure in all immuni-
zation programmes. The necessity to vaccinate older age 
groups, including adolescents and adults, is determined 
by  the  baseline  epidemiology  of  HBV  infection  in  the 
country (4). The disease has been preventable with a safe 
and effective vaccine  since 1982 (2). As of 2008, hepatitis 
B vaccine has been incorporated in 177 countries’ nation-
al infant immunization programs, and about 69% of the 
2008 birth cohort received all three doses of the vaccine 
(6).
The WHO/UNICEF coverage estimation between 1980 
and 2009 indicates that immunization coverage with all 
three doses of HBV vaccine in infants is in the range of 50 
to 79% in Iran (7). The study carried out by Alavian et al. 
states that over 35% of the population is exposed to HBV 
and approximately 2.5% are chronic carriers in Iran (1). A 
free vaccination against HBV is available in health care 
offices in Iran, but, to date, no mandatory vaccination 
program against HBV has been established for dentists. 
Furthermore, there are no documented data of infection 
rates in dentists and dental staff in Iran (8); in addition, 
there is no mandatory vaccination program against HBV 
for dentists in  the country (1). In this survey, only those 
who had received at least two doses of the HBV vaccine 
were  included.  The  assessment  of  anti-HBs  antibody 
titer in vaccinated dental students, professors, clinical 
assistants, and nonclinical staff in Faculty of Dentistry Hepat Mon. 2011;11(8):664-665
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indicated a statistically significant association between 
antibody titeration and age, occupation, smoking, com-
plete vaccination series, and time of the last vaccination. 
No significant association was observed between gender 
and anti-HBs antibody titeration, and the rate of immu-
nity was almost 70%, whereas approximately 18% were 
relatively immune and all others were nonimmune (1). 
In the multiple regression analysis, only age and time of 
the last vaccination were found to be independent pre-
dictors of immune system response (P < .001 for both 
variables).  The  highest  immune  response  was  found 
among dental students (20-29 y) in comparison to pro-
fessors and other staff (1). As a result, vaccination of more 
than 5 years, an incomplete vaccination, and older age 
have negative influences on immune response. This re-
sult might be a product of the strong emphasis on im-
portance of vaccination in dental students’ educational 
curriculum (1). The WHO position paper puts great em-
phasis on the introduction of immunization programs 
worldwide: it strongly recommends that all regions and 
associated countries develop goals for hepatitis B control 
according  to their epidemiological situation (7).
In Italy the anti-HBV universal vaccination was intro-
duced in 1991 for newborn and 12-year-old children, and 
at the beginning of the 20th century, the prevalence of 
HBV infection was under 2%. From the beginning of the 
compulsory vaccination campaign in 1991, there was a 
downfall in HBV incidence with a reduction of 40% from 
1988–91 to 1991–99. The reduction rate was 66% among 
0- to 14-year-old children and 59% among 15- to 24-year-
old  individuals  (9).  Health  care  workers  are  at  risk  of 
blood-borne, airborne, and droplet-spread transmission 
of infectious agents due to frequent and often intensive 
occupational  exposures,  which  include  percutaneous 
injury, contact with mucous membranes, or nonintact 
skin with blood or other potentially infectious bodily flu-
ids. Health care workers may also act as potential paths 
of nosocomial transmission of several infections to pa-
tients and other close contacts (10). In the study by Alvian 
et al. we noticed that 13% of health care workers were non-
immune, whereas 17.8% were partially immune; in other 
words, almost one third of the samples were exposed to 
HBV infection. It has been clearly recognized and docu-
mented in the literature that the usage of specific stand-
ard precautions and protective equipment is designed 
to decrease the risk of acquiring or transmitting occupa-
tional infections in health care settings. In particular, the 
most efficient methods of preventing several hospital-ac-
quired infections and resulting morbidity and mortality 
is through the usage of preexposure immunization (10). 
Vaccination of health care workers results in improved 
patient and employee safety and, therefore, immuniza-
tions are strongly recommended against several diseas-
es for health care personnel (11, 12). In conclusion, these 
results suggest the need for a national vaccination pro-
gram to improve immunization coverage among dental 
health care workers in Iran.
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